XM does not provide services to residents of the United States of America.

Nutrien misses third-quarter profit estimates as lower crop prices weigh



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>UPDATE 2-Nutrien misses third-quarter profit estimates as lower crop prices weigh</title></head><body>

Adds shares and details throughout

Nov 6 (Reuters) -Nutrien NTR.TO NTR.Nfell short of Wall Street expectations for third-quarter profit on Wednesday, as the fertilizer producerstruggled with lower crop prices, sending U.S.-listed shares of the company down 2.3% after the bell.

Tight global supply, low channel inventories and seasonal demand in several key markets have kept prices for nutrients such as potash and phosphate high at a time when crop prices have declined, forcing farmer to curb spending on fertilizers.

"Global phosphate markets remain tight supported by Chinese export restrictions and production outages in the U.S. We anticipate some impact on global demand due to tight supply and weaker affordability," the company said.

Nutrien lowered its outlook for annual phosphate sales volumes to be in the range of 2.4-2.5 million tonnes from 2.5-2.6 million tonnes previously.

However, Nutrien raised its annual forecast for potash sales volumes, owing to expectations of stronger demand in key markets. Other producers are also hopeful about a rebound in demand and prices during the second half of 2024.

The company's net profit fell nearly 70% to $25 million in the third quarter, while net sales declined 5% to $5.35 billion.

Lower sales volumes and a decline in seed margins in key markets led to a 23% fall in adjusted core profit at Nutrien's retail segment - its largest by revenue.

Nutrien's results are in contrast to peers including CF Industries CF.N, and Norwegian firmYara International YAR.OL, both of which posted higher quarterly profits.

The Saskatoon, Canada-basedfirm posted an adjusted profit of 39 cents per sharefor the three months ended Sept. 30, compared with analyst's estimates of 46 cents per share, according to data compiled by LSEG.



Reporting by Vallari Srivastava in Bengaluru; Editing by Maju Samuel

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.